Synairgen has confirmed commencement of first patient dosing in a trial of SNG001 in COVID-19
Bacteria-trapping protein that may provide a new target for tracking and treating breast cancer
Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) Pandemic
Broccoli or Botox… That is the question
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
COVID-19 Outbreak: Potential Effects on Phase 1 Units
The Role of Animal Infection Models in Antibacterial Drug Development
Tumour Blood Vessels as a Target for Treating Resistant Glioblastoma
The New Era of Drug Development for Rare Disease – Can it be Sustained?
Artificial Intelligence (AI) is helping in the search for new antibiotics